|
Home > Departments and Centers > Minnesota Urolith Center > Recommendations > Canine Magnesium Ammonium Phosphate (Struvite) Uroliths
Canine Magnesium Ammonium Phosphate (Struvite) Uroliths
In most dogs struvite uroliths occur as a sequela to urinary tract infections with urease producing microbes. Because of this, eradication or control of infections is the most important factor in preventing recurrence of most canine struvite uroliths.
Canine INFECTION-INDUCED Struvite Uroliths
Urolith Dissolution
- Prior to attempting dissolution, perform diagnostic studies to identify urolith size and location, as well as confirmation of urolith composition (urinalysis, radiography, analysis of retrieved stones, etc.).
- Perform urine culture and susceptibility to identify bacterial pathogens (if present), and select appropriate antimicrobial therapy. The fact that diuresis reduces the urine concentration of antimicrobic agents should be considered when formulating drug doses.
- Administer appropriate antimicrobial agent; continue therapeutic doses of antimicrobics until there is radiographic evidence of complete dissolution.
- Initiate therapy with a canned calculolytic diet that promotes acidic urine, diuresis, and is restricted in phosphorus and magnesium.
- In general, we do not use urine acidifying drugs in our medical protocols for dissolution of infection-induced struvite uroliths.
- Monitor response to therapy at appropriate intervals (every 2 to 4 weeks). Uroliths dissolved in an average of 12 weeks in dogs with infection-induced struvite uroliths fed a struvitolytic diet in addition to appropriate antimicrobics.
Minimizing Urolith Recurrence
- Perform appropriate diagnostic studies to eradicate and control bacterial urinary tract infections.
- Infection-induced struvite uroliths will not form in the absence of urease-positive microbial infections.
Canine STERILE Struvite Uroliths
Urolith Dissolution
- Prior to attempting dissolution, perform diagnostic studies to identify urolith size and location, as well as confirmation of urolith composition (urinalysis, radiography, analysis of retrieved stones, etc.).
- Initiate therapy with a canned calculolytic diet that promotes acidic urine, diuresis, and is restricted in phosphorus and magnesium.
- Monitor response to therapy at appropriate intervals (every 2 to 4 weeks). Uroliths dissolved in an average of 5 to 6 weeks in dogs with sterile struvite uroliths fed a struvitolytic diet
Minimizing Urolith Recurrence
- Encourage additional water consumption or feed a canned diet to promote diuresis.
- Feed a maintenance diet that is restricted in magnesium and phosphorus and promotes acidic urine.
- Use appropriate caution in dogs predisposed to calcium oxalate urolithiasis.
Early detection of small uroliths that recur despite appropriate medical therapy facilitates non-surgical removal by voiding urohydropropulsion. Uroliths removed by voiding urohydropropulsion should be quantitatively analyzed.
All prevention recommendations should be adjusted to meet individual patient's needs. We recommend follow-up urinalyses, serum chemistry profiles, and radiographs on a periodic basis.
PRECAUTION
The struvitolytic diets are relatively high in fat, which serves primarily as a source of calories. Because dietary fat is a risk factor for pancreatitis, the serum activity of pancreatic enzymes (amylase, lipase) should be monitored before initiating therapy in patients known to be at higher risk for pancreatitis. These tests should be repeated if signs of pancreatitis develop during therapy. Because abnormal increases in these enzymes are not pathognomonic for pancreatitis, other relevant findings should also be considered.
We emphasize that female Miniature Schnauzers are at increased risk for infection-induced struvite uroliths and pancreatitis. Likewise, patients with hyperadrenocorticism are at increased risk for urinary tract infections (which could include staphylococci) and pancreatitis. Although risk factors are not to be considered as synonymous with cause and effect, clients should be informed of these associations and advised of how to respond to adverse events if they occur. They should be informed about adverse events that need medical attention and those that need medical attention only if they continue or are bothersome. Consult references for further details.
Further references:
Lulich JP, Osborne CA, Unger LK, et al: Nonsurgical removal of urocystoliths by voiding urohydropropulsion. In Journal of the American Veterinary Medical Association. Vol 203, pp. 660-663, 1993
Osborne, CA, et al.: Medical dissolution and prevention of canine struvite uroliths: twenty years experience, The Veterinary Clinics of North America, Small Animal Practice, 29:73-113, 1999
Osborne CA, et al.: Canine Urolithiasis. Small Animal Clinical Nutrition 4th ed., 2000, pp. 605-688.

|
Feedback | Notice of Privacy Practices
|
|
|